Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.64

-0.2%

Jan 2 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2874)	8/9/2010 12:50:22 PM
From: Jibacoa	Read Replies (1) of 3722

GENT is bouncing up from the $4 level.<g> The stock is up 11.46% as it is now trading at its intraday H with volume still moderate, but about 1.5x its ADV bigcharts.marketwatch.com There are no news that I am aware. The ACTAY remains at $5 But with 4Qs of better revenues and after it reported on the black on the 1stQ(March) with an almost 400% better revenues, I will still keep a TT at $10.<g> In February, GENT received an initial payment of EUR 5.11M ($7.0M) from Sigma-Tau in connection with amending the existing license and supply agreement to include the commercialization of the prevention of Defibrotide in North America, Central America and South America. As of March 31, its cash position was about 4x its cash as of Dec.31.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next